Retatrutide (GLP-3) 15mg

Description

Retatrutide is a next-generation tri-agonist peptide developed for advanced metabolic research. Its unique design engages three critical pathways simultaneously—GLP-1, GIP, and GCGR—making it a compelling compound in laboratory studies focused on coordinated metabolic signaling and energy regulation.

These pathways are commonly associated with:

• Appetite signaling balance
• Nutrient-responsive metabolic coordination
• Adaptive metabolic output
• Energy-regulation dynamics

By targeting multiple signaling mechanisms at once, Retatrutide supports investigation into the complex interplay between metabolic timing, cellular communication, and systemic balance.

Each 15 mg vial is manufactured to strict research-grade standards to ensure purity, consistency, and reliability for in-vitro and preclinical laboratory use only.